People: Interleukin Genetics Inc (ILIU.PK)

ILIU.PK on OTC Markets Group

26 Feb 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Kornman, Kenneth 

Brief Biography

Dr. Kenneth S. Kornman, DDS, Ph.D., is President, Chief Executive Officer, Chief Scientific Officer, Director of Interleukin Genetics, Inc. He has been appointed as the Chief Executive Officer and Director of the company effective August 23, 2012. He was a member of Board of Directors from August 2006 through April 2010. Prior to founding the Company in 1986, Dr. Kornman was a Department Chairman and Professor at The University of Texas Health Center at San Antonio. He has also been a consultant and scientific researcher for many oral care and pharmaceutical companies. Dr. Kornman currently holds an academic appointment at Harvard University. He holds multiple patents in the pharmaceutical area, has published three books and more than 100 scientific papers and has lectured and consulted worldwide on the transfer of technology to clinical practice. Dr. Kornman also holds an MS (Periodontics) and Ph.D. (Microbiology-Immunology) from the University of Michigan.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
360,000 -- 858,071 1,218,070

Options Compensation

  Quantity Market Value
Exercisable 424,031 1,253,930.00
Unexercisable 90,000 58,500.00
Exercised 10,000 38,500.00
Search Stocks